Nissan Medical Industries Ltd (TLV:NISA)
Israel · Delayed Price · Currency is ILS · Price in ILA 813.10
0.00 (0.00%)
Aug 3, 2026, 5:24 PM IDT
Nissan Medical Industries Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.26 | 17.7 | 15.72 | 24.86 | 19.33 | 40.08 |
Short-Term Investments | 0.85 | - | 1.58 | 0.19 | 0.18 | 0.07 |
Cash & Short-Term Investments | 13.11 | 17.7 | 17.29 | 25.05 | 19.51 | 40.16 |
Cash Growth | -4.38% | 2.37% | -30.97% | 28.42% | -51.42% | -17.79% |
Accounts Receivable | 89.38 | 75.84 | 71.87 | 92.16 | 120.09 | 98.57 |
Other Receivables | 6.43 | 3.59 | 5.78 | 19.91 | 4.27 | 2.9 |
Receivables | 98.42 | 83.02 | 87.22 | 112.07 | 124.36 | 101.48 |
Inventory | 104.96 | 114.11 | 169.25 | 114.95 | 106.54 | 106.12 |
Prepaid Expenses | - | 1.45 | 1.7 | 1.43 | 2.31 | 1.3 |
Other Current Assets | - | 1.57 | 1.15 | 2.44 | 4.09 | 5.82 |
Total Current Assets | 216.49 | 217.84 | 276.61 | 255.94 | 256.8 | 254.86 |
Property, Plant & Equipment | 346.97 | 345.85 | 379.99 | 399.4 | 403.18 | 380.08 |
Long-Term Investments | 14.81 | 14.62 | 15.09 | 14.4 | 36.13 | 35.55 |
Goodwill | 35.24 | 35.24 | 35.24 | 35.24 | 35.24 | 59.04 |
Other Intangible Assets | 0.61 | 0.66 | 0.94 | 1 | 0.87 | 0.51 |
Other Long-Term Assets | - | - | - | - | 3.9 | - |
Total Assets | 614.11 | 614.21 | 707.88 | 705.98 | 736.12 | 730.04 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 70.3 | 61.35 | 85.63 | 78.37 | 84.17 | 73.74 |
Accrued Expenses | - | 13.67 | 13.58 | - | 13.02 | 16.72 |
Short-Term Debt | 137.82 | 91.12 | 81.81 | 58.21 | 51.07 | 34.9 |
Current Portion of Long-Term Debt | - | 48.59 | 63.34 | 56.68 | 64.35 | 58.77 |
Current Portion of Leases | 3.87 | 3.82 | 5 | 5.94 | 3.99 | 3.68 |
Current Income Taxes Payable | 0.71 | 0.71 | 0.71 | 3.18 | 2.12 | 2.64 |
Other Current Liabilities | 14.54 | - | - | 18.79 | - | - |
Total Current Liabilities | 227.23 | 219.26 | 250.07 | 221.17 | 218.71 | 190.44 |
Long-Term Debt | 34.12 | 34.73 | 45.76 | 69 | 123.25 | 133.74 |
Long-Term Leases | 11.92 | 11.5 | 6.59 | 8.43 | 8.42 | 9.75 |
Pension & Post-Retirement Benefits | 5.21 | 5.21 | 5.38 | 5.15 | 5.08 | 8.09 |
Long-Term Deferred Tax Liabilities | 34.9 | 36.4 | 45.3 | 47.46 | 48.56 | 44 |
Total Liabilities | 313.37 | 307.1 | 353.1 | 351.2 | 404.02 | 386.02 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 14.13 | 14.13 | 14.13 | 14.13 | 14.13 | 14.13 |
Additional Paid-In Capital | 27.24 | 27.24 | 27.24 | 27.24 | 27.24 | 27.24 |
Retained Earnings | 184.3 | 186.65 | 199.12 | 198.09 | 192.72 | 231.78 |
Treasury Stock | -1.28 | -1.28 | -1.28 | -1.28 | -1.28 | -1.28 |
Comprehensive Income & Other | -34.73 | -33.06 | -8.98 | -9.51 | -17.42 | -43.96 |
Total Common Equity | 189.68 | 193.69 | 230.24 | 228.68 | 215.41 | 227.92 |
Minority Interest | 111.07 | 113.42 | 124.54 | 126.11 | 116.69 | 116.1 |
Shareholders' Equity | 300.74 | 307.12 | 354.78 | 354.79 | 332.1 | 344.02 |
Total Liabilities & Equity | 614.11 | 614.21 | 707.88 | 705.98 | 736.12 | 730.04 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 187.72 | 189.76 | 202.5 | 198.26 | 251.08 | 240.84 |
Net Cash (Debt) | -174.61 | -172.06 | -185.21 | -173.21 | -231.57 | -200.69 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -19.20 | -18.94 | -20.39 | -19.07 | -25.49 | -22.09 |
Filing Date Shares Outstanding | 9.04 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
Total Common Shares Outstanding | 9.04 | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
Working Capital | -10.74 | -1.42 | 26.54 | 34.78 | 38.09 | 64.42 |
Book Value Per Share | 20.99 | 21.32 | 25.35 | 25.18 | 23.71 | 25.09 |
Tangible Book Value | 153.83 | 157.8 | 194.06 | 192.43 | 179.29 | 168.38 |
Tangible Book Value Per Share | 17.02 | 17.37 | 21.36 | 21.18 | 19.74 | 18.54 |
Machinery | - | 607.32 | 656.74 | 650.17 | 628.1 | 570.04 |